Sarcoma patient experience study halted after just 7 participants

NCT ID NCT06050434

Terminated Knowledge-focused Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated Apr 28, 2026 · Updated 20 times

Summary

This study aimed to understand how soft tissue sarcoma patients feel—symptoms, side effects, and quality of life—when they restart the chemotherapy drug trabectedin after a break. Only 7 people took part before the study was stopped early. The results may still help doctors learn about patient experiences during retreatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOFT-TISSUE SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Frankfurt Universitätsklinikum

Frankfurt am Main, Germany
HELIOS KLinikum Bad Saarow

Bad Saarow, Germany
HELIOS Klinikum Berlin Buch

Berlin, Germany
Uniklinikum Leipzig

Leipzig, Germany
Universitätsklinikum Tübingen

Tübingen, Germany
Universitätsmedizin Greifswald

Greifswald, Germany
Universitätsmedizin Göttingen

Göttingen, Germany
Universitätsmedizin Mainz

Mainz, Germany
Westfälische Wilhelms-Universität Münster

Münster, Germany

Conditions

Explore the condition pages connected to this study.

SOFT-TISSUE SARCOMA